Double strand break repair
Double strand break repair
批准号:
7964039
负责人:
Michael Seidman
金额:
$17.75万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Cell LineCellsChemistryDNADNA DamageDouble Strand Break RepairEndonuclease IFicusinFrequenciesGene ConversionGenetic RecombinationGenomeGenomicsHomingKnock-in MouseLifeLinkMammalian CellModificationNonhomologous DNA End JoiningNucleic AcidsOligonucleotidesPathway interactionsPsoralensResectedSiteTransgenic AnimalsWorkYeastsbasecrosslinkendodeoxyribonuclease SceIgene therapynovelprogramsrepairedresearch studytriple helix
中文摘要
来自外源供体DNA的信息可以通过同源定向修复(HDR)1途径引入基因组中。这些途径受到双链断裂(DSB)和DNA损伤(如链间交联(ICL))的刺激。我们已经采用了三螺旋形成寡核苷酸连接到peptide(pso-TFO),在一个特定的网站在活的哺乳动物细胞的基因组中的DNA ICL。具有靶区域同源性的双链体DNA的共引入导致供体的精确敲入,其频率比单独供体高2-3个数量级。 敲入在ERCC 1/XPF缺陷的细胞中被消除,ERCC 1/XPF参与重组途径以及交联修复。单独地,将单链寡核苷酸供体(SSO)与pso-TFO共引入。这些比双链体敲入供体的活性高10倍。与双链体供体相反,SSO功效在ERCC 1/XPF缺陷的细胞中进一步升高。切除的单链末端已被牵连作为关键中间体的序列调节SSO,以及双链体供体敲入。我们询问如果两者都与pso-TFO一起存在,供体物种之间是否会竞争这些末端。双链体供体敲入的频率不受100倍摩尔过量的SSO的影响。当归巢核酸内切酶I-SceI用于在靶位点启动HDR时,获得了相同的结果。我们的结论是,进入不同的HDR途径的DSB控制的因素以外的核酸合作伙伴在这些途径。基于在酵母中的工作,认为单链寡核苷酸供体进入单链退火途径。然而,我们的实验表明,单链寡核苷酸供体更可能进入双链断裂修复的非同源末端连接(NHEJ)途径。NHEJ被认为是一个非模板化的途径,我们的结论代表了这一观点的一个新的修改。
英文摘要
Information from exogenous donor DNA can be introduced into the genome via homology directed repair (HDR)1 pathways. These pathways are stimulated by double strand breaks (DSB) and by DNA damage such as interstrand crossinks (ICL). We have employed triple helix forming oligonucleotides linked to psoralen (pso-TFO) to introduce a DNA ICL at a specific site in the genome of living mammalian cells. Co-introduction of duplex DNA with target region homology resulted in precise knock-in of the donor at frequencies 2-3 orders of magnitude greater than with donor alone. Knock-in was eliminated in cells deficient in ERCC1/XPF which is involved in recombinational pathways as well as crosslink repair. Separately, single strand oligonucleotide donors (SSO) were co-introduced with the pso-TFO. These were 10 fold more active than the duplex knock-in donor. SSO efficacy was further elevated in cells deficient in ERCC1/XPF, in contrast to the duplex donor. Resected single strand ends have been implicated as critical intermediates in sequence modulation by SSO, as well as duplex donor knock-in. We asked if there would be a competition between the donor species for these ends if both were present with the pso-TFO. The frequency of duplex donor knock-in was unaffected by a 100-fold molar excess of the SSO. The same result was obtained when the homing endonuclease I-SceI was used to initiate HDR at the target site. We conclude that the entry of DSB into distinct HDR pathways is controlled by factors other than the nucleic acid partners in those pathways. Based on work in yeast it was believed that the single strand oligonuceotide donors entered a single strand annealing pathway. However our experiments suggest that the single strand oligonucleotide donors are more likely to enter the Non Homologous End Joining (NHEJ) pathway of double strand break repair. NHEJ is regarded as a nontemplated pathway and our conclusion represents a novel modification of this view.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Factors that modulate cellular homeostasis to overcome replicative stress in aging
-
批准号:10003698
-
项目类别:
-
资助金额:$10.0万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:10003713
-
项目类别:
-
资助金额:$88.57万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:7964038
-
项目类别:
-
资助金额:$36.31万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Double strand break repair
-
批准号:8148309
-
项目类别:
-
资助金额:$14.26万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:7592051
-
项目类别:
-
资助金额:$27.25万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
The Fanconi Anemia Pathway in Inflammatory Senescent Cells
-
批准号:10250900
-
项目类别:
-
资助金额:$13.02万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:8335914
-
项目类别:
-
资助金额:$72.13万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:9351956
-
项目类别:
-
资助金额:$84.81万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Factors that modulate cellular homeostasis to overcome replicative stress in aging
-
批准号:10250871
-
项目类别:
-
资助金额:$8.48万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Does the interaction of Progerin and PCNA provoke genome instability and the activation of inflammatory pathways?
-
批准号:9549377
-
项目类别:
-
资助金额:$9.45万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Gene Targeting Mediated By Triple Helix Forming Oligonucleotides
-
批准号:7964032
-
项目类别:
-
资助金额:$9.68万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
The Fanconi Anemia Pathway in Inflammatory Senescent Cells
-
批准号:10003720
-
项目类别:
-
资助金额:$14.29万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Gene Targeting Mediated By Triple Helix Forming Oligonucleotides
-
批准号:8148304
-
项目类别:
-
资助金额:$4.75万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
The Fanconi Anemia Pathway in Inflammatory Senescent Cells
-
批准号:9549375
-
项目类别:
-
资助金额:$12.15万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:8552459
-
项目类别:
-
资助金额:$96.62万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:10250891
-
项目类别:
-
资助金额:$70.27万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:10913136
-
项目类别:
-
资助金额:$481.82万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:8931583
-
项目类别:
-
资助金额:$93.11万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:8736608
-
项目类别:
-
资助金额:$87.66万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
Repair of localized DNA damage
-
批准号:7732308
-
项目类别:
-
资助金额:$33.42万
-
财政年份:--
-
负责人:Michael Seidman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
库否细胞(Kupffer cells)受体PirB/LILRB2在非酒精性脂肪性肝炎中的作用及机制研究
-
批准号:82470907
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2024
-
负责人:余学锋
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: